newsfilter
← Latest News
GlobeNewswire·

Imara Reports Full Year 2020 Financial Results and Business Highlights

Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell disease and beta-thalassemia Reports new Phase 2a open label extension clinical...